Gabrail Cancer Center Launches Study of Elranatamab and Low-Dose Lenalidomide
Gabrail Cancer and Research Center Receives FDA Clearance to Advance STAR-LLD and Elranatamab Study in Multiple Myeloma The Gabrail Cancer and Research Center, a PhaseWell Research site, has announced an…
Thermo Fisher Scientific Launches Multiskan™ Ease Microplate Reader for Simplified Analysis
Thermo Fisher Scientific Launches Multiskan Ease Absorbance Microplate Reader for Routine Laboratory Applications Thermo Fisher Scientific has announced the launch of the Thermo Scientific™ Multiskan™ Ease Absorbance Microplate Reader, a…
Cencora’s Accelerate Pharmacy Solutions Launches Cell and Gene Therapy Enablement for Health Systems
Cencora Launches Cell and Gene Therapy Enablement Service to Help Health Systems Expand Advanced Therapy Programs Cencora has launched a new service designed to help health systems evaluate, establish, and…
Rapalogix Health Establishes Research Lab at Princeton Innovation Center BioLabs to Advance Next-Generation Rapalogs
Rapalogix Health Expands Research Capabilities with New Laboratory at Princeton Innovation Center BioLabs Rapalogix Health, a biotechnology company focused on developing longevity-based approaches to skin health, has announced the establishment…
Scholar Rock Receives FDA Fast Track Designation for Apitegromab in FSHD as Phase 2 FORGE Trial Begins
Scholar Rock Advances Apitegromab Development for FSHD with FDA Fast Track and Orphan Drug Designations Scholar Rock (NASDAQ: SRRK), a global biopharmaceutical company focused on developing therapies for rare, severe,…
Biocytogen Signs VHH Antibody Licensing Deal with Qilu Pharmaceutical
Biocytogen and Qilu Pharmaceutical Enter Non-Exclusive Licensing Agreement for Fully Human VHH Antibody in Neuroscience Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (SSE: 688796; HKEX: 02315), a biotechnology company focused on the…
Naturmega to Introduce SUPRIAX2™ Solution to North American Market at SupplySide Global 2026
Naturmega to Introduce SUPRIAX2™ and Showcase Next-Generation Lipid Innovation at SupplySide Global 2026 Naturmega, an advanced lipid science company focused on omega-3 and next-generation lipid technologies, is preparing to introduce…
Dr. Tobias Janowitz Appointed Director of Cancer Research at Feinstein Institutes
Tobias Janowitz Appointed to Lead Cancer Research at Feinstein Institutes and Northwell Health The Feinstein Institutes for Medical Research has announced the appointment of Tobias Janowitz, MD, PhD, as director…
QPS Holdings Strengthens Elemental Bioanalysis Capabilities Through Laboratory Modernization
QPS Strengthens Elemental Bioanalysis Capabilities with Acquisition of Two NexION 2200 ICP-MS Systems QPS Holdings, LLC (QPS), a global contract research organization supporting pharmaceutical and drug development programs, has announced…
Transcat Expands Biomedical Calibration Services with Acquisition of Southeastern Biomedical
Transcat Acquires Southeastern Biomedical Associates for $12.8 Million to Expand Biomedical Calibration Services Transcat, Inc., a provider of accredited calibration services and test and measurement equipment, has announced the acquisition…
Perfuze Reports Final MARRS Trial Results Demonstrating Strong Reperfusion and First-Pass Performance in Stroke Patients
Perfuze Reports Strong Final MARRS Pivotal Study Results Supporting Millipede88 Aspiration System in Acute Ischemic Stroke Perfuze, a medical device company focused on advancing stroke intervention through next-generation catheter technology,…
Huonslab Secures Patent for Therapeutic Antibody Subcutaneous Injection Formulation Using HyDIFFUZE™ Platform
Huonslab Expands Intellectual Property Portfolio for HyDIFFUZE™ Platform to Advance Subcutaneous Biologic Drug Delivery Huonslab, the research and development subsidiary of Huons Global (KOSDAQ: 084110), has strengthened its position in…